Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience
UMass Chan Affiliations
Division of Hematology and Oncology, Department of MedicineDocument Type
Journal ArticlePublication Date
2020-07-01Keywords
anemiacoronavirus
COVID-19
pandemic
sickle cell anemia
viruses
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Health Services Administration
Hemic and Lymphatic Diseases
Infectious Disease
Virus Diseases
Metadata
Show full item recordAbstract
Coronavirus disease 19 (COVID‐19) has posed unparalleled challenges for health care communities, the general population, and in particular, for patients suffering from various comorbidities. Patients with hematological disorders, both benign and malignant need special attention during this crisis time to ensure uninterrupted delivery of optimal care (Sahu & Siddiqui, 2020).Source
Sahu KK, Siddiqui AD, Cerny J. Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience. Br J Haematol. 2020 Jul;190(2):e86-e89. doi: 10.1111/bjh.16880. Epub 2020 Jun 11. PMID: 32445595; PMCID: PMC7283851. Link to article on publisher's site
DOI
10.1111/bjh.16880Permanent Link to this Item
http://hdl.handle.net/20.500.14038/27628PubMed ID
32445595Related Resources
ae974a485f413a2113503eed53cd6c53
10.1111/bjh.16880